A direct control of MICA by the BCR/ABL oncogene in chronic myelogenous leukemia had been described [16], while the HER2-HER3 signalling was involved in the regulation of MICA/B expression in breast cancer cell lines [17, 18]. The gene discussed is MICA; the disease is breast cancer.